The objective of the present invention is to provide an agent which is useful for suppressing actual atherosclerosis and has few side-effects. The suppressant for atherosclerosis according to the present invention is characterized in comprising an anti-HMGB1 monoclonal antibody binding to C-tail of HMGB1 as an active component.
申请公布号
EP2484379(A4)
申请公布日期
2013.05.08
申请号
EP20100818899
申请日期
2010.09.27
申请人
NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY;SOWAKAI MEDICAL FOUNDATION
